Treatment of raised blool pressure in the population : session I : results from different countries. Paris, FRA, 1996/12/11.
The Canadian Heart Health Survey, in which all 10 Canadian provinces participated using a standardized protocol, provides data from 23,129 randomly selected participants.
The hypertension component of this survey indicates a prevalence of 22% ; among these hypertensives, 59% were aware of their elevated blood pressure status.
The breakdown of aware hypertensives indicates that 16% of those were treated and controlled, 24% were treated but not controlled, and 19% were neither treated nor controlled.
In terms of drug prescription pattern, angiotensin converting enzyme inhibitors, including angiotensin II antagonists, command the maximum market share of 27.7% ($36 million), followed by diuretics, calcium channel blockers, bêta-blockers, and others.
Although hypertension awareness and control have improved in the past 25 years, sustained efforts are warranted to control hypertension in Canada.
Mots-clés Pascal : Hypertension artérielle, Homme, Traitement, Antihypertenseur, Chimiothérapie, Canada, Amérique du Nord, Amérique, Prévalence, Efficacité traitement, Epidémiologie, Appareil circulatoire pathologie
Mots-clés Pascal anglais : Hypertension, Human, Treatment, Antihypertensive agent, Chemotherapy, Canada, North America, America, Prevalence, Treatment efficiency, Epidemiology, Cardiovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0377270
Code Inist : 002B02F05. Création : 25/01/1999.